BioNTech says ‘no evidence’ its jabs need adapting for variants
German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
by ·
German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
by · Published April 8, 2021
by · Published May 19, 2021
by · Published May 10, 2021